Skip to main content

Security report for pda.org

Parenteral Drug Association · Healthcare · United States

Low risk. 1 critical or high finding in SSL/TLS.

Security score

86/100

Risk levelLow

0–100, higher is better. How it is calculated

The Parenteral Drug Association (PDA) is a well-established global organization focused on providing science, technology, and regulatory information to the pharmaceutical and biopharmaceutical industries. Founded in 1946, the association offers educational courses, regulatory news, and industry events to professionals in the healthcare sector. The website reflects a professional and consistent brand image, targeting pharmaceutical professionals and regulatory specialists worldwide. Technically, the website employs modern web technologies including Bootstrap for layout, Font Awesome for icons, and Google Fonts for typography. It integrates multiple marketing and analytics tools such as HubSpot, Google Tag Manager, Hotjar, Facebook Pixel, and LinkedIn Insight Tag, indicating a mature digital marketing infrastructure. The site is hosted under a reputable registrar with a long-standing domain age, enhancing its credibility. From a security perspective, the site uses HTTPS and has domain transfer protections in place. However, it lacks DNSSEC and explicit security headers, which are recommended to enhance security posture. No privacy or cookie policies were detected in the provided content, which is a compliance gap especially under GDPR regulations. No incident response or vulnerability disclosure information is present, suggesting room for improvement in transparency and security readiness. Overall, the website is professional and trustworthy but would benefit from enhanced privacy compliance and security best practices to reduce risk and improve user trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching pda.org

This scan found 14 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
82
Security headers
80
Email security
80
DNS health
85
Network security
100
GDPR outside view
88
Average
86

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

PDA occupies a strong position as a niche association serving the pharmaceutical and biopharmaceutical sectors. Its business model centers on membership, education, and regulatory information dissemination. The organization targets industry professionals requiring up-to-date regulatory guidance and technical training. Revenue streams likely include membership fees, event registrations, and educational course sales. The presence of multiple marketing and tracking tools suggests active engagement in digital outreach and lead generation. The domain's long history and consistent branding support a stable market presence. No evidence of subsidiaries or parent companies was found, indicating an independent entity focused on its core sector.

Security posture

The website demonstrates a moderate security maturity level with HTTPS enabled and domain transfer lock status set. However, the absence of DNSSEC and security headers such as Content Security Policy (CSP), HTTP Strict Transport Security (HSTS), and X-Frame-Options indicates potential vulnerabilities to DNS spoofing and clickjacking attacks. The lack of visible privacy and cookie policies raises compliance concerns, particularly with GDPR. No incident response contacts or vulnerability disclosure mechanisms were found, which could delay response to security incidents. The use of multiple third-party marketing and analytics scripts increases the attack surface and privacy risks. Overall, the security posture is adequate but requires enhancements to meet best practices and regulatory requirements.

Recommendations

  1. Enable DNSSEC on the domain to protect against DNS spoofing and improve DNS security.
  2. Implement comprehensive privacy and cookie policies with clear user consent mechanisms to ensure GDPR compliance.
  3. Add security headers such as CSP, HSTS, X-Frame-Options, and X-Content-Type-Options to strengthen web security.
  4. Establish and publish an incident response policy and contact channels to improve transparency and readiness.
  5. Review and minimize third-party scripts to reduce privacy risks and improve site performance.

Contact details published on the site

Addresses
Legal name
Parenteral Drug Association
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Parenteral Drug Association
Description
PDA is a global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community.
Key services
Regulatory news and updates, Educational courses and training, Industry conferences and events, Technical publications
Content quality
good
Branding
consistent

Technology

Stack
Font Awesome 6 Pro, Bootstrap Grid, Google Fonts (Lato), YouTube Widget API, HubSpot scripts, Hotjar, LinkedIn Insight Tag, Facebook Pixel, Google Tag Manager
Frameworks
Bootstrap
Platforms
HubSpot
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • HTTPS enabled
  • ClientTransferProhibited domain status

Analytics and tracking

Services
Google Analytics (via Google Tag Manager), Hotjar, LinkedIn Insight Tag, Facebook Pixel
Tracking level
moderate
Privacy practices
poor

Advertising

Tracking pixels
Facebook Pixel, LinkedIn Insight Tag, Hotjar
Marketing tools
HubSpot
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is accessible with no blocking or WAF challenges.
  2. No explicit privacy, cookie, or terms of service policies found in the provided HTML snippet.
  3. Multiple marketing and analytics scripts are present, indicating moderate user tracking.
  4. No contact emails or phone numbers explicitly found in the provided content.
  5. WHOIS data shows a long-established domain with no privacy protection, consistent with a reputable organization.
  6. Website uses modern fonts and iconography with Font Awesome and Google Fonts.
  7. HubSpot platform is used for marketing and form handling.
  8. No security.txt or vulnerability disclosure information found.
  9. No explicit security or incident response policies detected.
Technical notes

Notes

The website uses a modern technology stack with Bootstrap for responsive design, Font Awesome for iconography, and Google Fonts for typography. HubSpot is leveraged for marketing automation and form handling, while analytics are managed through Google Tag Manager, Hotjar, Facebook Pixel, and LinkedIn Insight Tag. The site appears moderately performant with good mobile optimization and basic accessibility features. No explicit CMS was detected, suggesting a custom or proprietary platform. Hosting is managed via Network Solutions, LLC, consistent with the WHOIS data. Technical debt appears low, but the absence of DNSSEC and security headers represents a technical risk. SEO is supported by proper meta tags and structured data, though no JSON-LD or Open Graph tags were explicitly found in the provided snippet.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 85/100Low22 findingsView report
Reviews of this site

Share your experience with pda.org. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review pda.org.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.